Latest Insider Transactions at Crispr Therapeutics Ag (CRSP)
This section provides a real-time view of insider transactions for Crispr Therapeutics Ag (CRSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CRISPR Therapeutics AG to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CRISPR Therapeutics AG's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 24
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,751
+6.58%
|
$220,016
$16.21 P/Share
|
|
Dec 02
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,000
-7.63%
|
$825,000
$55.1 P/Share
|
|
Nov 11
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-6.79%
|
$1,650,000
$55.85 P/Share
|
|
Oct 14
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,293
-1.86%
|
$197,478
$46.28 P/Share
|
|
Oct 14
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,089
-1.71%
|
$50,094
$46.28 P/Share
|
|
Oct 13
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+3.48%
|
-
|
|
Oct 13
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,113
+3.21%
|
-
|
|
Aug 08
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
100,000
-31.01%
|
-
|
|
Jun 21
2024
|
Julianne Bruno Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,366
-33.29%
|
$188,496
$56.09 P/Share
|
|
Jun 20
2024
|
Julianne Bruno Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,000
+40.91%
|
-
|
|
Apr 15
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
19,582
-4.32%
|
$1,174,920
$60.14 P/Share
|
|
Apr 15
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,582
+7.92%
|
$372,058
$19.12 P/Share
|
|
Mar 15
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-4.48%
|
$1,440,000
$72.51 P/Share
|
|
Mar 15
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.06%
|
$380,000
$19.12 P/Share
|
|
Mar 15
2024
|
Raju Prasad Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,524
-35.24%
|
$253,728
$72.69 P/Share
|
|
Mar 14
2024
|
Raju Prasad Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
-
|
|
Mar 12
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,583
-2.15%
|
$339,142
$74.44 P/Share
|
|
Mar 12
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,146
-1.84%
|
$84,804
$74.44 P/Share
|
|
Mar 11
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+4.06%
|
-
|
|
Mar 11
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,802
-4.59%
|
$764,556
$78.26 P/Share
|
|
Mar 11
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.48%
|
-
|
|
Mar 11
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
2,801
-4.46%
|
$218,478
$78.26 P/Share
|
|
Mar 10
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,250
+8.27%
|
-
|
|
Mar 10
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
5,500
+8.04%
|
-
|
|
Feb 27
2024
|
Simeon George |
BUY
Grant, award, or other acquisition
|
Indirect |
1,048,951
+50.0%
|
$74,475,521
$71.5 P/Share
|
|
Feb 20
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,370
-3.18%
|
$503,230
$79.67 P/Share
|
|
Feb 20
2024
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
1,913
-3.23%
|
$151,127
$79.67 P/Share
|
|
Feb 18
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,250
+6.2%
|
-
|
|
Feb 18
2024
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
3,825
+6.06%
|
-
|
|
Feb 15
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-3.3%
|
$1,600,000
$80.88 P/Share
|
|
Feb 15
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.8%
|
$380,000
$19.12 P/Share
|
|
Jan 29
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
50,000
-10.57%
|
$3,000,000
$60.8 P/Share
|
|
Jan 29
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+17.4%
|
$950,000
$19.12 P/Share
|
|
Jan 16
2024
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-9.64%
|
$1,240,000
$62.5 P/Share
|
|
Jan 16
2024
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.8%
|
$380,000
$19.12 P/Share
|
|
May 30
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-1.55%
|
$1,625,000
$65.13 P/Share
|
|
May 30
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|
|
May 24
2023
|
Phuong Khanh Morrow Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,527
-36.42%
|
$164,255
$65.91 P/Share
|
|
May 23
2023
|
Phuong Khanh Morrow Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,938
+50.0%
|
-
|
|
Apr 25
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.06%
|
$1,250,000
$50.98 P/Share
|
|
Apr 25
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|
|
Mar 29
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-3.06%
|
$1,100,000
$44.57 P/Share
|
|
Mar 29
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+5.72%
|
$475,000
$19.12 P/Share
|
|
Mar 13
2023
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,305
-2.08%
|
$99,115
$43.22 P/Share
|
|
Mar 13
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,444
-1.21%
|
$406,092
$43.22 P/Share
|
|
Mar 11
2023
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.87%
|
-
|
|
Mar 11
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+2.25%
|
-
|
|
Mar 10
2023
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+4.91%
|
-
|
|
Mar 10
2023
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,833
+2.96%
|
-
|
|
Feb 27
2023
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
25,000
-2.11%
|
$1,200,000
$48.49 P/Share
|